Annual EBITDA
-$92.85 M
-$58.29 M-168.63%
31 December 2023
Summary:
CARGO Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$92.85 million, with the most recent change of -$58.29 million (-168.63%) on 31 December 2023. CRGX annual EBITDA is now -1528.11% below its all-time high of -$5.70 million, reached on 31 December 2021.CRGX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$40.12 M
+$2.15 M+5.09%
30 September 2024
Summary:
CARGO Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$40.12 million, with the most recent change of +$2.15 million (+5.09%) on 30 September 2024. Over the past year, it has dropped by -$5.70 million (-16.56%). CRGX quarterly EBITDA is now -283.59% below its all-time high of -$10.46 million, reached on 01 March 2023.CRGX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$147.33 M
-$5.70 M-4.03%
30 September 2024
Summary:
CARGO Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$147.33 million, with the most recent change of -$5.70 million (-4.03%) on 30 September 2024. Over the past year, it has dropped by -$74.85 million (-103.26%). CRGX TTM EBITDA is now -1307.85% below its all-time high of -$10.46 million, reached on 01 September 2022.CRGX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRGX EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -168.6% | -16.6% | -103.3% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
CRGX EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -1528.1% | at low | -283.6% | +5.1% | -1307.8% | at low |
5 y | 5 years | -1528.1% | at low | -283.6% | +5.1% | -1307.8% | at low |
alltime | all time | -1528.1% | at low | -283.6% | +5.1% | -1307.8% | at low |
CARGO Therapeutics EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$40.12 M(-5.1%) | -$147.33 M(+4.0%) |
June 2024 | - | -$42.27 M(+24.5%) | -$141.63 M(+21.7%) |
Mar 2024 | - | -$33.96 M(+9.6%) | -$116.35 M(+25.3%) |
Dec 2023 | -$92.85 M | -$30.98 M(-10.0%) | -$92.85 M(+28.1%) |
Sept 2023 | - | -$34.42 M(+102.6%) | -$72.49 M(+49.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | - | -$16.99 M(+62.5%) | -$48.53 M(+53.9%) |
Mar 2023 | - | -$10.46 M(-1.4%) | -$31.54 M(+49.6%) |
Dec 2022 | -$34.56 M(+506.1%) | -$10.61 M(+1.4%) | -$21.08 M(+101.4%) |
Sept 2022 | - | -$10.46 M | -$10.46 M |
Dec 2021 | -$5.70 M | - | - |
FAQ
- What is CARGO Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for CARGO Therapeutics?
- What is CARGO Therapeutics annual EBITDA year-on-year change?
- What is CARGO Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for CARGO Therapeutics?
- What is CARGO Therapeutics quarterly EBITDA year-on-year change?
- What is CARGO Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for CARGO Therapeutics?
- What is CARGO Therapeutics TTM EBITDA year-on-year change?
What is CARGO Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CRGX is -$92.85 M
What is the all time high annual EBITDA for CARGO Therapeutics?
CARGO Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$5.70 M
What is CARGO Therapeutics annual EBITDA year-on-year change?
Over the past year, CRGX annual earnings before interest, taxes, depreciation & amortization has changed by -$58.29 M (-168.63%)
What is CARGO Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CRGX is -$40.12 M
What is the all time high quarterly EBITDA for CARGO Therapeutics?
CARGO Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$10.46 M
What is CARGO Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CRGX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$5.70 M (-16.56%)
What is CARGO Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CRGX is -$147.33 M
What is the all time high TTM EBITDA for CARGO Therapeutics?
CARGO Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$10.46 M
What is CARGO Therapeutics TTM EBITDA year-on-year change?
Over the past year, CRGX TTM earnings before interest, taxes, depreciation & amortization has changed by -$74.85 M (-103.26%)